About the role
About this opportunity:
We are seeking a Manager, FP&A to help grow the Freenome Finance team. The FP&A Manager will support planning for key business processes and requires strong financial reporting, forecasting, planning and modeling skills and excellent communication and collaboration skills and business judgment. The ideal candidate is technically strong, highly analytical, and able to translate financial data and business trends into actionable insights for cross-functional partners. You will help improve financial visibility, strengthen planning processes, and provide actionable insights that support Freenome’s growth and scale.
The role reports to the Vice President FP&A and is a critical and high visibility position interacting heavily with the business.
You are passionate about Finance and desire to have a significant impact on the continued growth of an organization dedicated to changing the entire landscape of cancer.
What you’ll do:
Strategic Business Partnering:
- Serve as the dedicated financial advisor to business leaders and budget owners (R&D, Commercial, Operations), translating complex financial data into a narrative that drives decision-making.
- Identify financial opportunities by deeply understanding the drivers of our diagnostic platform and product offerings.
Proactive Budget Management:
- Drive corporate planning processes through rigorous oversight of departmental budgets and forecasts, ensuring alignment with Freenome’s strategic priorities.
- Empower budget owners with self-service tools while providing the “guardrails” necessary for a public company environment.
Actionable Analysis and Reporting:
- Deliver effective monthly and quarterly reporting that drives accountability, scaled by leveraging technology.
- Establish, track, and report KPIs that measure financial performance, operational efficiency, and progress against strategic priorities, partnering with the business to ensure metrics are actionable and relevant as the organization scales.
- Ensure resources are aligned with strategic and operating priorities and clear financial controls are maintained.
- Identify key business issues that impact short-term and long-range market forecasts; clearly and proactively surface these issues.
- Influence key decisions by delivering high value financial analysis that highlights root causes of variance, trends, and identify actionable opportunities to invest, reduce costs, and mitigate risks.
Systems Innovation and AI Integration:
- Build and refine the forecasting tools, short-term and long-term forecast models.
- Support the implementation, buildout and continuous improvement of key financial systems, such as ERP, planning and budgeting systems and business intelligence tools.
- Leverage automation and emerging tools, including AI where appropriate, to streamline reporting, reduce manual work, and improve forecast accuracy.
- Collaborate with the broader organization to drive process and systematic improvements across the Company.
Must haves:
- Bachelor’s degree in Accounting/Finance/Business.
- Minimum of 8 years of progressive Finance/FP&A experience, including at least 3 years in FP&A and/or business partnering in a fast-paced, high-growth environment. Life sciences, healthcare, biotech, diagnostics, or medical device experience is preferred.
- Willingness to roll up your sleeves, handle large amounts of data and build complex financial models.
- Excellent organizational and analytical skills with the ability to creatively solve problems with a data-driven approach.
- Ability to articulate complex financial concepts in understandable terms to non-finance professionals.
- Demonstrated ability to think strategically while maintaining a command of the details.
- Demonstrated ability to develop client group business acumen and provide actionable insights and recommendations to improve KPIs.
- Advanced Excel skills and experience with ERP systems, e.g., NetSuite, SAP; experience with FP&A software, business intelligence tools, automation, or AI-driven analytics is a plus.
- Passion for automation and continuous improvement to reduce human error and dependency on spreadsheets.
- Proven experience building financial management processes, management reporting, and establishing the financial discipline required in a scaling organization.
- Well-versed in the requirements of a public company and adherence to all applicable laws, rules, and regulations.
Nice to haves:
- MBA/CPA or CFA a plus.
- Experience in diagnostics, life sciences, lab operations, reagent manufacturing, or other regulated healthcare environments.
- Knowledge of clinical diagnostics development, operations, portfolio management, and commercial go-to-market planning.
Benefits and additional information:
The US target range of our base salary for new hires is $146,775 - $183,750. You will also be eligible to receive equity, cash bonuses, and a full range of medical, financial, and other benefits depending on the position offered. Please note that individual total compensation for this position will be determined at the Company’s sole discretion and may vary based on several factors, including but not limited to, location, skill level, years and depth of relevant experience, and education. We invite you to check out our career page @ freenome.com/job-openings/ for additional company information.
Freenome is proud to be an equal-opportunity employer, and we value diversity. Freenome does not discriminate on the basis of race, color, religion, marital status, age, national origin, ancestry, physical or mental disability, medical condition, pregnancy, genetic information, gender, sexual orientation, gender identity or expression, veteran status, or any other status protected under federal, state, or local law.
Applicants have rights under Federal Employment Laws.
- Family & Medical Leave Act (FMLA)
- Equal Employment Opportunity (EEO)
- Employee Polygraph Protection Act (EPPA)
#LI-HYBRID
Aplyr's read
Freenome is pioneering early cancer detection through AI-driven blood tests, attracting talent in tech, healthcare, and data science to innovate patient outcomes.
What's promising
- •Freenome's AI-driven platform offers a cutting-edge approach to early cancer detection.
- •The company has a strong focus on leveraging machine learning for healthcare innovation.
- •Freenome's mission aligns with a growing demand for non-invasive cancer screening solutions.
What to watch
- •The biotechnology sector faces intense competition in cancer detection technology.
- •Regulatory hurdles in healthcare can delay product development and market entry.
- •Freenome's success heavily relies on the accuracy and reliability of its AI algorithms.
Why Freenome
- •Freenome integrates AI and machine learning directly into its cancer detection process.
- •The company's focus on blood-based tests offers a less invasive alternative to traditional methods.
- •Freenome's platform aims to detect multiple cancer types simultaneously, enhancing early intervention.
Aplyr’s read is generated by AI from public sources. Was it useful?
About Freenome
Freenome is a biotechnology company focused on developing a blood-based multi-cancer early detection platform. By leveraging advanced artificial intelligence and machine learning, Freenome aims to transform cancer screening and improve patient outcomes through earlier detection.